trending Market Intelligence /marketintelligence/en/news-insights/trending/pl6gtattyfld7rd-saep3w2 content esgSubNav
In This List

GeoVax names CEO

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


GeoVax names CEO

Smyrna, Ga.-based GeoVax Labs Inc., a clinical-stage biotechnology company, appointed David Dodd as president and CEO, effective Sept. 1.

Dodd succeeds Robert McNally, who has retired but will remain a director of the company.

Dodd became a board member of the company in March 2010 and was elected chairman in January 2011. He served as CEO and director of Medizone International Inc., a medical device manufacturer, from September 2017 to June 2018.